Research progress on sclerotherapy of ovarian endometriotic cyst
10.3969/j.issn.1671-8348.2025.09.034
- VernacularTitle:卵巢子宫内膜异位囊肿硬化治疗研究进展
- Author:
Shan LU
1
;
Ying JIA
Author Information
1. 重庆医科大学附属第一医院妇产科,重庆 400016
- Keywords:
ovarian endometriotic cyst;
sclerotherapy;
ethanol;
lauromacrogol
- From:
Chongqing Medicine
2025;54(9):2193-2199
- CountryChina
- Language:Chinese
-
Abstract:
Ovarian endometriotic cyst(OEC)is a common pathological type of endometriosis,which is more common in women of childbearing age.The patients often present with symptoms such as lower abdomi-nal pain,dysmenorrhea,abdominal masses and infertility.Currently,the conventional treatment methods for OEC are the drug therapy and surgical treatment.However,the pharmacological treatment is difficult to cure the lesion completely,while the surgical treatment is easy to injure the ovarian tissue and increases the diffi-culty of reoperation.Therefore,sclerotherapy has emerged as a promising alternative treatment.By using scle-rosing agents such as ethanol or lauromacrogol,sclerotherapy directly acts OEC to achieve the therapeutic goal.This treatment method has the advantages including minimal wound,rapid recovery,definite efficacy and minimal impact on the ovarian function.Under certain conditions,sclerotherapy may serve as an effective al-ternative to traditional treatments,providing more options for OEC patients.This article aims to review the research progress of OEC sclerotherapy,explore its potential,challenges and future research directions in clini-cal application,and provide more treatment decision for making basis for clinicians.
